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Abstract Kisspeptin (encoded by KISS1) is a crucial
activator of reproductive function. The role of kisspeptin
has been studied extensively within the hypothalamus but
little is known about its significance in other areas of the
brain. KISS1 and its cognate receptor are expressed in the
amygdala, a key limbic brain structure with inhibitory
projections to hypothalamic centers involved in go-
nadotropin secretion. We therefore hypothesized that
kisspeptin has effects on neuronal activation and repro-
ductive pathways beyond the hypothalamus and par-
ticularly within the amygdala. To test this, we mapped
brain neuronal activity (using manganese-enhanced MRI)
associated with peripheral kisspeptin administration in ro-
dents. We also investigated functional relevance by mea-
suring the gonadotropin response to direct intra-medial
amygdala (MeA) administration of kisspeptin and
kisspeptin antagonist. Peripheral kisspeptin administration
resulted in a marked decrease in signal intensity in the
amygdala compared to vehicle alone. This was associated
with an increase in luteinizing hormone (LH) secretion. In
addition, intra-MeA administration of kisspeptin resulted in
increased LH secretion, while blocking endogenous
kisspeptin signaling within the amygdala by administering
intra-MeA kisspeptin antagonist decreased both LH se-
cretion and LH pulse frequency. We provide evidence for
the first time that neuronal activity within the amygdala is
decreased by peripheral kisspeptin administration and that
kisspeptin signaling within the amygdala contributes to the
modulation of gonadotropin release and pulsatility. Our
data suggest that kisspeptin is a ‘master regulator’ of re-
productive physiology, integrating limbic circuits with the
regulation of gonadotropin-releasing hormone neurons and
reproductive hormone secretion.
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Introduction
Kisspeptin, encoded by the KISS1 gene, is an arginine–
phenylalanine amide neuropeptide that acts on the
kisspeptin receptor (KISS1R). A critical role for the
KISS1/KISS1R system in reproductive function was
identified a decade ago from studies showing that humans
with KISS1R or KISS1 inactivating mutations failed to go
through puberty (de Roux et al. 2003; Seminara et al.
2003; Topaloglu et al. 2012), while conversely activating
mutations of KISS1R or KISS1 resulted in central preco-
cious (early) puberty (Teles et al. 2008; Silveira et al.
2010).
KISS1 neurons in the hypothalamus secrete
kisspeptin, which stimulates KISS1R-expressing go-
nadotropin-releasing hormone (GnRH) neurons (located
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predominantly in the preoptic area in rodents, POA) to
release GnRH. GnRH then stimulates gonadotropin
[luteinizing hormone (LH) and follicle stimulating
hormone (FSH)] and subsequent sex steroid release
from the anterior pituitary and gonads, respectively
(reviewed in Pinilla et al. 2012). Key reproductive
populations of KISS1 neurons in rodents have been
identified in two regions of the hypothalamus, the ar-
cuate nucleus (ARC, equivalent to the infundibular
nucleus in primates) and anteroventral periventricular
nucleus (AVPV) (Clarkson et al. 2009).
However, KISS1/KISS1R expression is not limited to the
hypothalamus (Clarkson et al. 2009; Lee et al. 1999), yet
there is a paucity of data exploring the brain more widely.
Given the established role of the KISS1/KISS1R system in
reproduction, an area of particular interest is the amygdala,
whose functions contribute to a broad range of social and
reproductive behaviors (Murray 2007), as well as go-
nadotropin secretion and estrous cyclicity (Beltramino and
Taleisnik 1978; Bagga et al. 1984). Furthermore, neu-
roanatomical studies have demonstrated neuronal projec-
tions between the amygdala and hypothalamic regions that
regulate reproductive hormone release such as the ARC,
AVPV and POA (Canteras et al. 1995; Hahn et al. 2003;
Keshavarzi et al. 2014).
The finding of KISS1R expression within the human and
rodent amygdala (Lee et al. 1999; Muir et al. 2001) as well
as the more recent observation of sex steroid-dependent
KISS1 expression within the rodent amygdala (Kim et al.
2011) has heightened interest in the extra-hypothalamic
roles of kisspeptin. We therefore hypothesized that
kisspeptin has effects on neuronal activation and repro-
ductive pathways beyond the hypothalamus and par-
ticularly within the amygdala.
In a first test of our hypothesis (Study 1, Fig. 1a), we
investigated the effects of peripheral kisspeptin adminis-
tration on brain neuronal activity (including the amyg-
dala) using manganese-enhanced MRI (MEMRI), as well
as on LH secretion in rodents. We employed MEMRI,
which utilizes the paramagnetic manganese ion as a
contrast agent with ability to mimic Ca2? and enter
neurons through voltage-gated Ca2? channels upon neu-
ronal activation. This technique therefore permits tempo-
ral assessment of in vivo neuronal response to
physiological and pharmacological stimuli (Kuo et al.
2007; Hankir et al. 2012).
In a second test of our hypothesis (Study 2, Fig. 1b),
we assessed the effects of direct administration into the
amygdala of kisspeptin or a kisspeptin antagonist on
gonadotropin release to determine the functional sig-
nificance of kisspeptin signaling specifically within the
amygdala.
Materials and methods
Animals
Animal rights
Studies were performed in accordance with the United
Kingdom Animals (Scientific Procedures) Act 1986 and
were approved by the Imperial College London and King’s
College London Ethical Review Committee.
Adult C57/BL6 male mice (8–10 weeks) and adult
Sprague–Dawley female rats (12–14 weeks) obtained from
Harlan Laboratories (Oxfordshire, UK) were housed under
Fig. 1 Scheduled summary of rodent studies. a Study 1: peripheral
(ip) bolus of kisspeptin or vehicle was administered and subsequent
changes in plasma kisspeptin, serum LH and neuronal activity in pre-
selected CNS regions of interest (ROIs) were assessed (by mangane-
se-enhanced MRI). Kisspeptin administration resulted in a significant
increase in serum LH levels. This was accompanied by significant
decreases in neuronal activity in the amygdala (Amy) and preoptic
area (POA) after kisspeptin administration when compared to vehicle
administration. b Study 2A: a bolus of kisspeptin or vehicle was
administered directly into the medial amygdala (MeA) and subse-
quent serum LH and LH pulsatility was assessed. Administration of
kisspeptin into the MeA increased LH secretion. Study 2B: a bolus of
kisspeptin antagonist or vehicle was administered directly into the
medial amygdala (MeA) and subsequent serum LH and LH pulsatility
was assessed. Administration of kisspeptin antagonist into the MeA
decreased serum LH and LH pulsatility
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controlled conditions (12:12 h light/dark cycle, lights on
0700 hours; temperature, 22 ± 2 C; food and water ad li-
bitum). There were no weight differences between
kisspeptin and vehicle-treated groups in each study.
Study 1: effects of peripheral kisspeptin
administration on plasma kisspeptin (Study 1A),
serum LH (Study 1B) and CNS neuronal activity
(Study 1C) in adult male mice (Fig. 1a)
We investigated the temporal effects of kisspeptin admin-
istration on circulating kisspeptin (Study 1A) and LH
levels (Study 1B) during a 2-h time course to determine the
optimal period for MEMRI scanning (Study 1C). Since the
blood volume obtained from repeated tail clip sampling in
mice is too small for multiple hormone analysis, two
complementary studies were carried out (one for mea-
surement of plasma kisspeptin (Study 1A) and the other for
measurement of serum LH (Study 1B) following kisspeptin
injection). Study 1B also served to confirm kisspeptin
bioactivity.
Study 1A: effects of peripheral kisspeptin administration
on plasma kisspeptin levels
Mice were exposed to equivalent conditions to MEMRI
scanning but outside the scanner. Mice (n = 8/group) were
anesthetized with 2 % isoflurane in oxygen at a flow rate of
2 L/min and maintained by 1 % isoflurane–oxygen. Blood
(20 ll) was obtained from tail tip pre- (0 min) and post-
bolus intraperitoneal injection (20, 40, 60, 120 min) of
either kisspeptin-54 (0.04 nmol/g), or equivalent vehicle
volume (gelofusine). Kisspeptin was dissolved in saline
containing gelofusine (B. Braun Medical Ltd, UK) and was
administered by intraperitoneal (ip) injection. This dose of
kisspeptin was chosen as it has been previously shown to
robustly increase LH secretion following ip injection in
mice (Curtis et al. 2010; Jayasena et al. 2011).
Blood was collected in lithium–heparin cuvettes. Plasma
was separated and stored at -20 C. Measurement of
plasma kisspeptin immunoreactivity (kisspeptin-IR) was
performed using an established radioimmunoassay (Dhillo
et al. 2005). Plasma kisspeptin levels were compared using
two-way ANOVA. P \ 0.05 was considered statistically
significant.
Study 1B: effects of peripheral kisspeptin administration
on serum LH levels
A separate but identical experiment to Study 1A was per-
formed to determine the time profile of LH secretion fol-
lowing peripheral kisspeptin administration (n = 8/group).
Blood was collected into plain cuvettes. Serum was
separated and stored at -20 C. Serum LH was assayed by
magnetic-bead luminex immunoassay (inter- and intra-as-
say variation \20 and \15 %, respectively) (Milliplex
Mouse LH Magnetic-Bead Assay, Merck Millipore, UK).
Serum LH levels were compared using two-way ANOVA.
P \ 0.05 was considered statistically significant.
Study 1C: effects of peripheral kisspeptin administration
on CNS neuronal activity using MEMRI
Having established a time course for the effects of pe-
ripheral kisspeptin administration on circulating kisspeptin
and LH, we examined the effects of peripheral adminis-
tration of kisspeptin on central neuronal activity during this
time course in pre-determined 3D regions of interest
(ROIs).
Protocol
Mice were acclimatized in a holding room adjacent to the
MRI laboratory for 24 h pre-scanning. Mice were anes-
thetized as in Study 1A and 1B. MEMRI was performed by
a 9.4-T MRI scanner (Agilent Technologies) with quadra-
ture birdcage coil (Magnetic Resonance Labs) (Kuo et al.
2007; Hankir et al. 2012). Transverse slices covering whole
brain were acquired repeatedly in an array, 66 times
(127 min), using a 2D Fast Spin Echo multislice sequence
with parameters: TR 1.8 s, effective TE 5.6 ms (6 echoes,
spacing 5.6 ms, k-space center = 1), FOV 25 9 25 mm,
matrix 192 9 192, 46 contiguous axial, 0.4-mm-thick sli-
ces and 2 averages. After the third acquisition, 100 mmol
MnCl2 was infused by intravenous cannula (tail vein), at a
rate of 0.2 ml/h and total dose of 0.5 lmol/g. Based on the
results of Study 1, an effect of kisspeptin on circulating
kisspeptin and LH levels is readily observed at 20 min
post-kisspeptin administration. Manganese uptake reaches
steady state within 20–60 min depending on brain region
(Kuo et al. 2007); therefore, kisspeptin-54 (0.04 nmol/g,
n = 8) or equivalent volume vehicle (n = 7) ip injection
was administered simultaneously with initiation of MnCl2
infusion to ensure that the kisspeptin-induced changes in
manganese uptake were detectable within the scanning
period (Silva et al. 2004).
ROIs and image analysis
Image-processing software (FSL, UK) was used to define
ROIs on a standardized mouse brain template. 3D ROIs
were neuroanatomically defined and corresponded to; left
amygdala, right amygdala, left ARC, right ARC, AVPV,
POA, and anterior pituitary with reference to standard
mouse brain atlas (Paxinos and Franklin 2001) (Fig. 2). To
ensure adequate manganese entry into the circulation only
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scans where signal intensity (SI) in the fourth ventricle
increased [20 % over baseline within ten acquisitions
were included. 4D brain images were extracted and spa-
tially normalized (SPM5, FIL Methods Group; AFNI,
Medical College of Wisconsin and FSL, UK), before SI
time-course measurements were performed in the ROIs.
MEMRI data analysis
Data were normally distributed (assessed by Kolmogorov–
Smirnov test). Percentage change SI from baseline (pre-
manganese) to post-manganese infusion was calculated for
each ROI (percentage enhancement, PE). PE was analyzed
between kisspeptin and vehicle-treated groups by com-
paring entire time-course SI enhancement curve by general
estimated equation (GEE) analysis as previously published
(Kuo et al. 2007, 2010; Hankir et al. 2012). GEE performs
general linear regression analysis using all values in each
animal and therefore accounts for within-animal correla-
tion between adjacent values (Zeger and Liang 1986). GEE
analysis permitted assessment of significance of effect
between kisspeptin and vehicle-treated groups. To assess
quantitative size of effect, we utilized area under curve
analysis (AUC). P \ 0.05 was considered statistically
significant.
Study 2: effect of intra-medial amygdala (MeA)
administration of kisspeptin (Study 2A) and
kisspeptin antagonist (Study 2B) on LH secretion
and LH pulsatility in adult female rats (Fig. 1b)
Study 1 showed that peripheral administration of kisspeptin
inhibits neuronal activity in the amygdala and this is as-
sociated with an increase in LH secretion. In Study 2, we
investigated the functional significance of kisspeptin sig-
naling in the amygdala on LH secretion. To determine the
effect of kisspeptin receptor agonism in the amygdala, we
administered kisspeptin directly into the amygdala and
measured LH release and pulsatility (Study 2A). To de-
termine the role of endogenous kisspeptin signaling in the
amygdala in LH release and pulsatility, we administered a
kisspeptin antagonist directly into the amygdala (Study
2B).
Surgical procedures
All surgical procedures were carried out under anesthesia
induced by ketamine (Vetalar, 100 mg/kg, intraperitoneal
(ip); Pfizer, Sandwich, UK) and xylazine (Rompun, 10 mg/
kg, ip; Bayer, Newbury, UK). Two weeks before ex-
periments took place rats were bilaterally ovariectomized
Fig. 2 Adult mouse brain
region of interests (ROIs) used
for the MEMRI study. Relative
positions of the transverse MRI
slices within the adult mouse
brain obtained during MEMRI
scanning. Representative cross-
sectional images are shown
from MEMRI scans through 3D
ROIs from which signal
intensity profiles were generated
corresponding to the amygdala,
arcuate nucleus (ARC),
anteroventral periventricular
nucleus (AVPV), preoptic area
(POA including medial septum),
and anterior pituitary (AP)
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(OVX) and implanted with a silastic capsule (inner di-
ameter 1.57 mm; outer diameter 3.18 mm; Sanitech, Ha-
vant, UK), filled to a length of 25 mm with 17 b-estradiol
(E2; Sigma-Aldrich Ltd., Poole, UK) dissolved at a con-
centration of 20 lg/ml arachis oil (Sigma-Aldrich). The
E2-containing capsule produced circulating concentrations
of E2 within the range observed during the diestrous phase
of the estrous cycle (Cagampang et al. 1991). At the time of
ovariectomy, all rats were also fitted with a bilateral guide
cannula (22 gauge; Plastics One, Roanoke, VA, USA) di-
rected toward the MeA for microinfusion of pharmaco-
logical agents as previously described (Li et al. 2009). The
stereotaxic coordinates for implantation being 3.4 mm
lateral, 3.14 mm posterior to bregma, and 8.6 mm below
the surface of the dura according to the rat brain atlas of
Paxinos and Watson (1986). The guide cannula was se-
cured using dental cement (Associated Dental Product,
Swindon, UK) and fitted with a dummy cannula (Plastics
One) to maintain patency. A stainless steel slotted screw
(Instec Laboratories, Boulder, CO, USA) was affixed to the
surface of the skull posterior to the guide cannula using
dental cement. The rats were housed singly and allowed
10 days of recovery before being fitted with two indwelling
cardiac catheters via the jugular veins, to facilitate serial
blood sampling. The catheters were exteriorized at the back
of the head and enclosed within a 30 cm metal spring tether
(Instec Laboratories) secured to the slotted screw. The
distal end of the tether was attached to a two-channel fluid
swivel (Instec Laboratories), which allowed the rat free to
move around the enclosure. Experimentation commenced
3 days later. Each animal was used once only. Correct
cannula placement in the MeA was confirmed by micro-
scopic inspection of 30 lm brain sections. Only data from
animals with correct cannula placement were analyzed.
Study 2A: effect of intra-MeA kisspeptin administration
on LH secretion
Protocol On the morning of experimentation, an intra-
MeA injection cannula (Plastics One, Roanoke, VA) with
extension tubing preloaded with kisspeptin-10 or vehicle
[artificial cerebrospinal fluid (aCSF)], was inserted into the
MeA guide cannula. The distal end of the tubing, prefilled
with aCSF was extended outside of the cage to allow re-
mote microinfusion without disturbing the rat during the
experiment. Microinfusion was performed manually over
5 min using a 5 ll syringe (Hamilton, Bonaduz, Switzer-
land). One of the two cardiac catheters was then attached
via the fluid swivel to a computer-controlled automated
blood sampling system, which allows for the intermittent
withdrawal of small blood samples (25 ll) every 5 min for
6 h without disturbing the rats. Once connected, the ani-
mals were left undisturbed for 1 h before sampling
commenced between 1000 and 1100 hours. After removal
of each 25 ll blood sample, an equal volume of hep-
arinized saline (50 U/ml normal saline; Wockhardt,
Wrexham, UK) was automatically infused into the animal
to maintain patency of the catheter and blood volume.
After 2 h controlled blood sampling, kisspeptin-10 or ve-
hicle was infused intra-MeA over 5 min. Rodents received
a single dose of 100 pmol or 1 nmol kisspeptin-10 (n = 9
per treatment group) in 400 nl aCSF, bilaterally. These
doses of kisspeptin were chosen as they have previously
been shown to increase LH secretion following injection
into the ARC or POA (Li et al. 2009). Control rats (n = 7)
received 400 nl aCSF. Blood sampling continued for a
further 4 h and samples were frozen in a -20 C freezer
until assay for LH. A double-antibody RIA supplied by the
National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK, Bethesda, MD, USA) was used to de-
termine LH concentrations in the 25 ll whole-blood sam-
ples. Referenced preparation was rLH-RP-3. The
sensitivity of the assay was 0.093 ng/ml. The intra-assay
variation was 7.3 %, and the inter-assay variation was
10 %.
Study 2B: effect of intra-MeA kisspeptin antagonist
administration on LH secretion and LH pulsatility
Protocol For the infusion of a kisspeptin antagonist
(peptide-234; Sigma-Aldrich, Dorset, UK) into the MeA,
the intra-MeA injection cannulae preloaded with peptide-
234 were set up in the same way as described above in
Study 2A. Rats were administered 50 pmol peptide-234
(n = 9) in 400 nl aCSF over a period of 5 min after 2 h
controlled blood sampling and then the same dosage was
repeated on two further occasions at an interval of 30 min.
These doses of kisspeptin antagonist were selected as they
have been previously shown to inhibit LH pulsatility fol-
lowing injection into the ARC (Li et al. 2009). Blood
sampling procedures were set up as described above for LH
measurement. We selected the MeA in the amygdala as this
is the predominant site for kisspeptin signaling within the
amygdala (Kim et al. 2011).
LH pulsatility analysis
Detection of LH pulses was established by the algorithm
ULTRA (Van Cauter 1988). The effect of pharmacological
agents on pulsatile LH secretion was analyzed by com-
paring the mean LH pulse interval in the 2 h period pre-
ceding treatment with that in first hour and second to
fourth hour post-treatment periods. LH pulse interval was
calculated by the time interval between the peak value of
each consecutive LH pulse detected in the appropriate
analysis period. The LH pulse interval was not calculated
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for animals receiving intra-MeA injections of the larger
dose of kisspeptin (1 nmol), since LH pulses were not re-
liably detectable during the post-treatment period because
of the dynamic increase in circulating levels of LH. The
significance of the effect of treatments on LH pulse inter-
vals was compared with control animals injected with ve-
hicle, at the same time points, as well as with the mean
pulse interval during the 2 h pre-treatment period. The
effect of pharmacological agents on overall LH secretion
was calculated by comparing the area under the LH profile
[area under the curve (AUC)] for the 2 h pre-treatment
period with that in first hour and second to fourth hour
post-treatment periods, using SigmaPlot version 11 (Systat
Software, San Jose, CA, USA). Statistical significance was
tested using one-way ANOVA followed by Dunnett’s test.
All data were shown as mean ± SEM. P \ 0.05 was
considered statistically significant.
Results
Study 1A: peripheral kisspeptin administration
increases circulating kisspeptin levels
Vehicle administration had no effect on plasma kisspeptin-
IR. Kisspeptin administration resulted in dramatic in-
creases in plasma kisspeptin-IR compared to vehicle be-
tween 20 and 120 min post-administration (P \ 0.0001,
Fig. 3a).
Study 1B: peripheral kisspeptin administration
increases LH secretion
Vehicle administration alone had no effect on serum LH.
However, kisspeptin administration increased LH com-
pared to vehicle injection between 20 and 120 min post-
administration (P \ 0.0001) (Figs. 1a, 3b). The peak LH
increase occurred at 120 min post-kisspeptin (vehicle
?0.6 ± 0.2 ng/ml, kisspeptin ?3.7 ± 0.5 ng/ml,
P \ 0.0001 vs. vehicle). The timings of the observed in-
creases in LH (20–120 min) were similar to those at which
increased plasma kisspeptin-IR was observed after
kisspeptin administration (Fig. 3a).
Study 1C: peripheral kisspeptin administration
modulates CNS neuronal activity as determined
by MEMRI
Having demonstrated increased LH secretion after
kisspeptin administration, we proceeded to assess the ef-
fects of kisspeptin on central neuronal activity using
MEMRI. We assessed the relative signal intensity (SI) as a
marker of neuronal activation in selected, neu-
roanatomically defined 3D regions of interest (ROIs) over a
120-min time course (to encompass the hormonal changes
observed in Study 1).
Amygdala
Reduced SI was observed in the amygdala after kisspeptin
administration compared to vehicle alone (GEE analysis:
vehicle left amygdala vs. kisspeptin left amygdala,
P = 0.0257; vehicle right amygdala vs. kisspeptin right
amygdala, P = 0.0085, Figs. 1a, 4a, b).
The mean SI decreased by 20 % in the left amygdala
and 22 % in the right amygdala (mean SI AUC in PE.min,
vehicle left amygdala 885.1 ± 82.2, kisspeptin left amyg-
dala 704.1 ± 40.3; vehicle right amygdala 983.4 ± 76.6,
kisspeptin right amygdala 762.3 ± 51.9). This reduction of
SI in the amygdala (Fig. 4a, b) occurred at a similar time to
the increases in circulating kisspeptin (Fig. 3a) and LH
(Fig. 3b).
Fig. 3 Effect of peripheral kisspeptin or vehicle administration on
circulating kisspeptin and LH levels. Time course of increases in
a plasma kisspeptin-IR and b serum luteinizing hormone (LH) after
intraperitoneal injection of kisspeptin-54 (0.04 nmol/g) or vehicle at
time 0 min in adult male mice. n = 8/group. ***P \ 0.0001. Plasma
kisspeptin-IR and serum LH increased significantly after kisspeptin
compared to vehicle injection. Data presented as mean ± SEM.
Arrow represents time of bolus injection of kisspeptin or vehicle
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ARC and AVPV
No significant differences in SI between kisspeptin and
vehicle administration were observed in either the ARC
(Fig. 4c, d) or AVPV (Fig. 4e).
POA
Reduced SI was observed in the POA after kisspeptin ad-
ministration compared to vehicle (P = 0.0234, Figs. 1a,
4f).
Anterior pituitary
Although there was a trend towards an initial increase in SI
in the first 20 min after kisspeptin injection, no significant
differences were observed over the full time course of the
experiment (Fig. 4g).
Study 2A: intra-medial amygdala (MeA)
administration of kisspeptin stimulates overall LH
secretion
Having observed decreased neuronal activity in the
amygdala following peripheral kisspeptin administration,
we proceeded to determine the role of kisspeptin signaling
in the amygdala in LH secretion. To do this, we adminis-
tered kisspeptin directly into the amygdala. Direct intra-
MeA administration of kisspeptin resulted in a dose-de-
pendent increase in circulating levels of LH determined by
AUC (Figs. 1b, 5b, c, e; P = 0.007, kisspeptin vs. vehicle
100 pmol; P = 0.002, kisspeptin 1 nmol vs. vehicle;
Fig. 4 Changes in CNS neuronal activity following kisspeptin or
saline administration. Time course of T1-weighted MRI signal change
in the left amygdala (a), right amygdala (b), left ARC (c), right ARC
(d), AVPV (e), POA (f) and anterior pituitary (g) after intravenous
MnCl2 infusion into adult male mice also receiving an intraperitoneal
injection of kisspeptin (n = 8), or vehicle (n = 7). Arrows indicate
the start time of MnCl2 infusion and bolus injection of kisspeptin or
vehicle. Gray bar represents duration of MnCl2 infusion. Signal
intensity (SI) was measured as percentage enhancement (PE) over
baseline. **P \ 0.01, *P \ 0.05. Data presented as mean ± SEM
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Fig. 5 Effect of kisspeptin or
kisspeptin antagonist injection
into the amygdala on LH
secretion. Effect of micro-
injection of kisspeptin or
kisspeptin antagonist (peptide-
234) into the medial amygdala
(MeA) on LH secretion and
pulse frequency in
ovariectomized rats implanted
with estradiol capsules.
Representative LH profiles
demonstrating the effect of
intra-MeA administration (at
time marked by ‘down arrow’)
of vehicle (a), kisspeptin
100 pmol (b), kisspeptin 1 nmol
(c), or kisspeptin antagonist
(d) on pulsatile LH secretion.
Direct administration of
kisspeptin into the amygdala
dose-dependently increased LH
secretion (b, c) shown by
increased area under curve
(AUC) of the LH profile (e).
Direct administration of
kisspeptin antagonist into the
amygdala decreased LH AUC
(e) and more specifically
suppressed LH pulse frequency
(d, f). The prolonged increase in
LH in response following
1 nmol kisspeptin
administration precluded
reliable LH pulse determination.
*P \ 0.05 vs. vehicle;
#P \ 0.05 vs. dose of 100 pmol
kisspeptin at same time point;
n = 5–7 per group. Data
presented as mean ± SEM
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P = 0.002, kisspeptin 1 nmol vs. kisspeptin 100 pmol).
LH pulse frequency was not affected by intra-MeA injec-
tion of 100 pmol kisspeptin (Fig. 5f), and the dramatic and
prolonged increase in LH in response to 1 nmol kisspeptin
precluded reliable LH pulse detection (Fig. 5c, e, f). Intra-
MeA administration of vehicle (aCSF) did not affect AUC
or LH pulse frequency (Fig. 5a, e, f).
Study 2B: intra-MeA administration of a kisspeptin
antagonist decreases pulsatile and overall LH
secretion
To determine if endogenous kisspeptin signaling in the
amygdala affects LH secretion, we administered kisspeptin
antagonist directly into the amygdala. Intra-MeA adminis-
tration of the kisspeptin antagonist, peptide-234, decreased
the frequency of LH pulses (i.e. increased pulse interval
Figs. 1b, 5d, f; P \ 0.001, vehicle vs. kisspeptin antagonist)
and reduced LH secretion (Figs. 1b, 5e; P = 0.041, vehicle
vs. kisspeptin antagonist).
Discussion
Although our understanding of the KISS1/KISS1R system
has improved dramatically in the past decade, the vast
majority of work has focussed on the hypothalamus. The
effects of kisspeptin in other areas of the brain have been
less well characterized. Additional data are now required as
we refine our understanding of kisspeptin action and de-
velop therapeutics based on the KISS1/KISS1R system. To
this end, recent advances in neuroimaging afford us a
unique opportunity to study kisspeptin further.
Current evidence suggests that the amygdala exerts a
predominantly ‘inhibitory brake’ on the reproductive axis
and on reproductive behavior. For example, electrical
stimulation of the amygdala delays puberty (Bar-Sela and
Critchlow 1966). Conversely, lesioning of the amygdala
results in hypersexuality (Kluver and Bucy 1997), in-
creased circulating LH (Lawton and Sawyer 1970), and
prevents the stress-induced suppression of LH pulses (Lin
et al. 2011). Here, we report for the first time that, in adult
rodents, peripherally administered kisspeptin inhibits neu-
ronal activation in the amygdala and is temporally asso-
ciated with an increase in LH secretion (Fig. 1a).
Therefore, these data suggest that kisspeptin administration
may release the tonic ‘inhibitory brake’ exerted by the
amygdala on the reproductive axis to stimulate go-
nadotropin secretion.
Although KISS1 and KISS1R are expressed in the rodent
(and human) amygdala (Lee et al. 1999; Muir et al. 2001;
Clarkson et al. 2009; Kim et al. 2011), peripherally ad-
ministered kisspeptins are not thought to cross the blood–
brain barrier (Herde et al. 2011). Previous studies have
shown that, although central administration of kisspeptin
increases C-FOS expression in GnRH neurons in the POA
(Irwig et al. 2004), no change in GnRH neuronal C-FOS
expression has been observed after peripheral kisspeptin
administration in adult mice (d’Anglemont de Tassigny
et al. 2010). This is in keeping with both our current study
and previous studies suggesting that peripherally adminis-
tered kisspeptin may predominantly act on GnRH neuron
dendritic terminals outside the blood–brain barrier which
therefore do not undergo cell body activation (Herde et al.
2011; Xu et al. 2012).
However, it has previously been shown that peripheral
kisspeptin administration can alter the neuronal activity of
central neurons (Scott and Brown 2011). In the current
study, we observed an overall inhibitory effect of pe-
ripherally administered kisspeptin on neuronal activity in
the amygdala in association with an increase in LH se-
cretion. Similarly, we observed a decrease in neuronal
activity in the POA in association with an increase in LH
secretion (Fig. 1a). It is important to consider that
MEMRI cannot distinguish directly between activation of
one population of neurons and deactivation of another
within the same ROI, and hence represents an overall net
effect.
It is interesting to consider reasons for the decrease in
net neuronal activity observed in the amygdala and POA
following peripheral administration of kisspeptin. It is well
established that kisspeptin can modulate central c-
aminobutyricacidergic (GABA) activity (Zhang et al. 2009;
Neal-Perry et al. 2009). Neal-Perry et al. (2009) using
microdialysis techniques in adult rodents in vivo, observed
that kisspeptin administration directly into the POA de-
creased local GABA release by over 50 %, while simul-
taneously stimulating robust LH secretion. Consistent with
this Zhang et al. (2009), demonstrated that kisspeptin ad-
ministration decreases the GABAergic input to GnRH
neurons in the POA in adult rodent brain slices. Further-
more, GABA neurons inhibit GnRH activity and resultant
LH secretion (Neal-Perry et al. 2009; Garcia-Galiano et al.
2012; Zhang et al. 2009; Zuure et al. 2013; Martin et al.
2014). Therefore, it is possible that the decreased neuronal
activity detected in the amygdala and POA in the current
study represents a decrease in GABA neuronal activity as a
consequence of kisspeptin administration. A reduction in
GABA activity would lead to reduced inhibition of GnRH
neurons and hence an increase in LH secretion as observed
in the current study. In keeping with this, there are estab-
lished networks of kisspeptin and GABA neurons and in-
terneurons in both the amygdala and POA with projections
between these areas (Canteras et al. 1995; Veinante et al.
1997; Hahn et al. 2003; Pinilla et al. 2012; Di Giorgio et al.
2014; Keshavarzi et al. 2014).
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An alternative hypothesis to explain the decreased
neuronal activity observed in the POA is provided by the
nitric oxide (NO) synthesizing neuronal population within
the POA which has been implicated directly in the
regulation of GnRH neuronal activity in the mouse
(Clasadonte et al. 2008) and rat (Grossman et al. 1994).
These neurons are able to sense circulating kisspeptin and
relay this information onto adjacent GnRH neurons (Han-
chate et al. 2012), the activity of which is decreased by
neuronal NO in keeping with the current study (Clasadonte
et al. 2008). Recent mathematical modeling suggests that
the neuroendocrine brain could use these peripheral hor-
mone-mediated episodes of NO release to synchronize
GnRH neuronal activity resulting in increased go-
nadotropin release consistent with the LH increases ob-
served in our study (Bellefontaine et al. 2014).
We also examined manganese uptake in other hy-
pothalamic regions with well-established reproductive
functions. Neuronal activity in the ARC and AVPV was
unaffected by peripheral kisspeptin administration com-
pared to vehicle. This is consistent with th absence of the
expression of KISS1R in these areas in mice and the in-
ability of peripherally administered kisspeptin to reach
these areas (Herbison et al. 2010).
Finally in Study 1, we evaluated the influence of
kisspeptin on manganese uptake within the anterior pitu-
itary, the site of LH release from the gonadotropin response
to GnRH. Although we observed an initial non-significant
increase over the first 20 min, this did not continue through
the full time course. This could be due to rapid habituation
of the gonadotroph cell population by the pharmacological
concentrations of kisspeptin administered which are known
to cause sustained GnRH release which stimulates the
gonadotrophs (Han et al. 2005). However, given that go-
nadotrophs represent a fraction of the cell population of the
anterior pituitary, it is also possible that any effect on go-
nadotroph activity was masked by other, non-gonadotroph
activity.
An important consideration of the MEMRI technique in
Study 1 is the use of anesthesia which typically suppresses
neuronal activity and hence potentially makes any changes
in response to an external stimulus harder to detect.
However, a degree of anesthesia is required to keep the
animal stationary and minimize any effects of stress on the
reproductive axis (Chand and Lovejoy 2011). In addition,
the depth of anesthesia correlates with suppression of
MEMRI signal intensity (Silva and Bock 2008). Hence the
anesthetic dose used in this study was based on previous
studies in our laboratory which ascertained the lowest
anesthetic dose at which reliable immobility was achieved
while permitting assessment of the effects of peripherally
administered hormones on CNS neuronal activity
(Chaudhri et al. 2006; Kuo et al. 2006, 2007). The effects
of the anesthesia should not significantly limit the results of
the current study as both vehicle- and kisspeptin-treated
mice received the same anesthetic protocol. Furthermore,
the LH increases observed following kisspeptin adminis-
tration in the current study were similar to those seen fol-
lowing peripheral administration of kisspeptin to non-
anesthetized rodents in other studies suggesting that
kisspeptin action is indeed maintained under anesthesia
(Curtis et al. 2010; Jayasena et al. 2011).
Having observed in Study 1 that peripheral kisspeptin
administration results in decreased neuronal activity in the
amygdala and is associated with increased circulating LH
levels (Fig. 1a), we next investigated the role of kisspeptin
signaling within the amygdala in LH secretion and LH
pulsatility in Study 2 (Fig. 1b). To do this, we used a well-
established rat model (Li et al. 2009) to inject peptides
directly into the amygdala and sampled blood frequently to
evaluate LH secretion and pulsatility in freely moving
animals. This is technically difficult to perform in mice.
To determine the role of amygdala KISS1R agonism in LH
secretion, we infused kisspeptin directly into the amyg-
dala. We observed that intra-amygdala infusion of
kisspeptin stimulated LH secretion. To test for a role of
endogenous amygdala kisspeptin in LH release, we infused
a kisspeptin antagonist directly into the amygdala. This
resulted in a decrease in LH secretion and pulsatility
(Fig. 1b).
Therefore, these data suggest that endogenous amygdala
kisspeptin signaling regulates not only GnRH secretion
(and hence LH secretion), but also may regulate the GnRH
pulse generator per se to alter LH pulsatility. Furthermore,
previous work has also demonstrated an increase in LH
secretion after intra-POA administration of kisspeptin
highlighting the importance of both the amygdala and POA
in stimulating LH secretion via kisspeptin signaling (Li
et al. 2009). This, in addition to our finding of marked
changes in neuronal activation within the amygdala and
POA following peripheral kisspeptin administration, pro-
vides evidence of a novel pathway involving the amygdala
and hypothalamus through which kisspeptin mediates its
neurophysiological effects.
It is important to note that we performed Study 1 in male
and Study 2 in female adult rodents. Male mice were used
in Study 1 as they do not have cyclical changes in repro-
ductive hormones and KISS1 expression (Kim et al. 2011)
coupled with our experience in employing MEMRI in mice
(Kuo et al. 2006, 2007, 2010; Hankir et al. 2012). To allow
for accurate intra-amygdala kisspeptin injection and sen-
sitive LH pulse detection we employed a female rat model
(OVX ? E2) established in our laboratory for Study 2 (Li
et al. 2009; Lin et al. 2011). Importantly, KISS1 expression
in the amygdala is similar in both male and female mice
and rats (Kim et al. 2011).
Brain Struct Funct
123
An additional consideration is the possibility of diffu-
sion of administered kisspeptin from the amygdala into the
ventricular system of the rats, resulting in an effect via the
hypothalamus to trigger LH secretion. The dose of
kisspeptin which stimulated LH secretion when adminis-
tered directly into the medial amygdala in rats in the cur-
rent study was 100 pmol. However, previous data have
demonstrated that the intracerebroventricular (icv) admin-
istration of 100 or 300 pmol doses of kisspeptin in rats
does not significantly stimulate LH secretion when com-
pared to vehicle (Thompson et al. 2004; Pheng et al. 2009).
This suggests that in our current study, kisspeptin is having
its actions within the amygdala rather than diffusing into
the ventricular system to have effects at the hypothalamus.
However, local genetic manipulation studies would add
further confirmation of a direct action of kisspeptin in the
amygdala.
Our findings open up future directions in which roles of
kisspeptin outside the hypothalamus may be studied further
using neuroimaging techniques. Given our observations of
changes in amygdala neuronal activity in response to
kisspeptin and a direct association with LH secretion, fu-
ture work may focus on the KISS1/KISS1R system and
sexual behaviors attributed to the amygdala. Along these
lines, Kauffman and colleagues (2007) demonstrated that
KISS1R expression is essential for olfactory-mediated
partner preference behavior but further behavioral studies
are now warranted.
In summary, we demonstrate that peripheral kisspeptin
administration decreases overall neuronal activity within
the amygdala and increases LH secretion (Fig. 1a). An
increase in LH secretion is also observed when kisspeptin
is administered directly into the amygdala, while con-
versely blocking of endogenous kisspeptin signaling within
the amygdala inhibits LH secretion and LH pulsatility
(Fig. 1b).
To our knowledge, this is the first demonstration of
kisspeptin signaling outside the hypothalamus directly
modulating reproductive hormone release. Our data there-
fore provides evidence that kisspeptin is a ‘master regula-
tor’ of reproduction, integrating limbic circuits with the
modulation of GnRH neurons and gonadotropin release.
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